Petersen, P. C. (2021) “A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma”, Acta Oncologica, 60(7), pp. 948–953. doi: 10.1080/0284186X.2021.1928281.